- Home
- HAVA vs PALI Comparison
HAVA vs PALI Comparison
Compare HAVA & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$1.76
Company Overview
Basic Information| Metric | HAVA | PALI |
|---|---|---|
| Founded | 2024 | 1996 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 206.9M | 240.2M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | HAVA | PALI |
|---|---|---|
| Price | $9.99 | $1.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | 144.0K | ★ 3.0M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $260,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1500.39 |
| 52 Week Low | $9.90 | $0.55 |
| 52 Week High | $10.01 | $2.64 |
Technical Indicators
Market Signals| Indicator | HAVA | PALI |
|---|---|---|
| Relative Strength Index (RSI) | 58.00 | 50.25 |
| Support Level | $9.94 | $1.57 |
| Resistance Level | $10.01 | $1.93 |
| Average True Range (ATR) | 0.01 | 0.11 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 49.75 | 54.05 |
Price Performance
Historical Comparison HAVA
PALI
About HAVA Harvard Ave Acquisition Corporation Class A Ordinary Share
Harvard Ave Acquisition Corp is a blank check company.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.